Replies to post #45494 on Cdex, Inc. (fka CDEX)

[Amanita]

Nice CDEX SCAM propaganda


The Company provides a ValiMed medication validation system product line in healthcare market, which consists of two products, such as ValiMed CCT and the ValiMed G4/5 System.

Is the G4/5 really a product line? And again is the CCT available anymore? The answer to both those is of course no.


The company will continue development of the prop G4 as long as it takes to keep the insiders in the "Money". The Id2 product line? "Verticals" , Explosives? Brand protection? Geez!

Here is the rest of the New York Times report that wasn't written by the perps.....The unavoidable truth.




Key Fundamentals
P/E ratio n.a.
Earnings per share –$0.01
Revenue $110.5K
Profit margin –654.23%
Return on equity –3,831.74%